ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Designing Programmable Peptide Nucleic Acid-based Nanovaccines for Anticancer Immune Activation.
Yanyu Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it